Oxazole-Based Compounds As Anticancer Agents

(E-pub Ahead of Print)

Author(s): Maria A. Chiacchio*, Giuseppe Lanza, Ugo Chiacchio, Salvatore V. Giofrè, Roberto Romeo, Daniela Iannazzo, Laura Legnani.

Journal Name: Current Medicinal Chemistry

Abstract:

Heterocyclic compounds represent a significant target for anti-cancer research and drug discovery, due to their structural and chemical diversity. Oxazoles, with oxygen and nitrogen atoms present in the core structure, enable various type of interactions with different enzymes and receptors, favoring the discovery of new drugs. Aim of this review is to describe the most recent reports on the use of oxazole-based compounds in anticancer research, with reference to the new discovered iso/oxazole-based drugs, to their synthesis and to the evaluation of the most biologically active derivatives. The corresponding dehydrogenated derivatives, i.e. iso/oxazolines and iso/oxazolidines, are also reported.

Keywords: Oxazole, Isoxazole, Oxazoline, Oxazolidine, Anticancer activity, Synthesis.

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/0929867326666181203130402
Price: $95